QT
KNSA icon

Quantbot Technologies’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Quantbot Technologies’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.8K Buy
+279
New +$14.5K ﹤0.01% 1790
2025
Q3 		– Sell
-1,565
Closed -$43.3K – 1945
2025
Q2 		$43.3K Buy
+1,565
New +$39.8K ﹤0.01% 1498
2023
Q1 		– Sell
-5,604
Closed -$83.9K – 1811
2022
Q4 		$83.9K Buy
+5,604
New +$81.6K 0.01% 1188
2022
Q1 		– Sell
-4,800
Closed -$56K – 1856
2021
Q4 		$56K Buy
+4,800
New +$59K ﹤0.01% 1000
2021
Q3 		– Sell
-2,754
Closed -$38K – 1709
2021
Q2 		$38K Buy
+2,754
New +$41.8K ﹤0.01% 1117

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Quantbot Technologies's KNSA Position: Q2 2026 in Review

Quantbot Technologies opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q2 2026: 279 shares worth $17.8K. The stake represents ﹤0.01% of the portfolio and ranks #1790 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in KNSA as recently as Q2 2025.

Quantbot Technologies first reported a position in KNSA in Q2 2021 and has held it in 5 quarters since. The position peaked at $83.9K in Q4 2022. 267 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Quantbot Technologies held 279 shares of Kiniksa Pharmaceuticals worth $17.8K as of Q2 2026.
  • Kiniksa Pharmaceuticals was a new Quantbot Technologies position in Q2 2026.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1790 holding.
  • Quantbot Technologies first reported a position in Kiniksa Pharmaceuticals in Q2 2021 and has held it in 5 quarters since.
  • Quantbot Technologies's Kiniksa Pharmaceuticals position peaked at $83.9K in Q4 2022.
  • 267 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.